Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-17-018159
Filing Date
2017-11-02
Accepted
2017-11-02 16:27:30
Documents
66
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q prog20170930_10q.htm 10-Q 911534
2 EXHIBIT 31.1 ex_97779.htm EX-31.1 15098
3 EXHIBIT 31.2 ex_97780.htm EX-31.2 14901
4 EXHIBIT 32 ex_97781.htm EX-32 8201
  Complete submission text file 0001437749-17-018159.txt   5171578

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT pgnx-20170930.xml EX-101.INS 1240405
6 XBRL TAXONOMY EXTENSION SCHEMA pgnx-20170930.xsd EX-101.SCH 52743
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pgnx-20170930_cal.xml EX-101.CAL 38878
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pgnx-20170930_def.xml EX-101.DEF 312617
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pgnx-20170930_lab.xml EX-101.LAB 284794
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pgnx-20170930_pre.xml EX-101.PRE 342456
Mailing Address ONE WORLD TRADE CENTER 47TH FLOOR NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER 47TH FLOOR NEW YORK NY 10007 646-975-2500
PROGENICS PHARMACEUTICALS INC (Filer) CIK: 0000835887 (see all company filings)

EIN.: 133379479 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23143 | Film No.: 171172780
SIC: 2834 Pharmaceutical Preparations